GLP3-RT<\/b>\u00a0is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.<\/p>\n
<\/p>\n
It is a new entrant into the rapidly-expanding space of anti-obesity peptides. It is known as a GGG tri-agonist. This means that it\u00a0 works at all of the incretin receptors including GLP-1 and GIP as well as the glucagon receptor itself. Research indicates that it may be the most effective weight loss peptide yet developed, with some studies showing a rapid and sustained weight loss response as high as 24% of total body weight[1]. It is thought to promote weight loss by increasing energy expenditure as well as decreasing energy consumption. It does the former via action at the glucagon receptor and the latter through both central and peripheral appetite control.<\/p>\n","protected":false},"excerpt":{"rendered":"
The newest research peptide for weight loss.\u00a0 Users have been reporting tremendous reduction in ‘food noise’, weight loss and blood sugar control.<\/p>\n","protected":false},"featured_media":88,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[20,21],"product_tag":[26,22,24],"class_list":{"0":"post-87","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-glp","7":"product_cat-weight-loss","8":"product_tag-appetite-control","9":"product_tag-glp","10":"product_tag-weight-loss","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-simple"},"yoast_head":"\n